NCT01383603View on ClinicalTrials.gov

Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Cat Allergy
Interventions
BIOLOGICAL

Cat-PAD

Intradermal injection 1 x 4 administrations 4 weeks apart

Trial Locations (1)

L9C3N6

St. Joseph's Healthcare Hamilton, Hamilton

Sponsors

Collaborators (1)

Adiga Life Sciences, Inc.
All Listed Sponsors
collaborator

Adiga Life Sciences, Inc.

INDUSTRY

lead

Circassia Limited

INDUSTRY